These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36353266)

  • 1. Risks and benefits of oral anticoagulants for stroke prophylaxis in atrial fibrillation according to body mass index: Nationwide cohort study of primary care records in England.
    Nakao YM; Nakao K; Wu J; Nadarajah R; Camm AJ; Gale CP
    EClinicalMedicine; 2022 Dec; 54():101709. PubMed ID: 36353266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Direct Oral Anticoagulants in Atrial Fibrillation Patients Across Different Body Mass Index Categories.
    Barakat AF; Jain S; Masri A; Alkukhun L; Senussi M; Sezer A; Wang Y; Thoma F; Bhonsale A; Saba S; Mulukutla S
    JACC Clin Electrophysiol; 2021 May; 7(5):649-658. PubMed ID: 33812834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk.
    Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
    Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):730-738. PubMed ID: 34694379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Outcomes Between Direct Oral Anticoagulants, Warfarin, and Antiplatelet Monotherapy Among Chinese Patients with Atrial Fibrillation: A Population-Based Cohort Study.
    Li X; Pathadka S; Man KKC; Ng VWS; Siu CW; Wong ICK; Chan EW; Lau WCY
    Drug Saf; 2020 Oct; 43(10):1023-1033. PubMed ID: 32557348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight.
    Lee SR; Choi EK; Park CS; Han KD; Jung JH; Oh S; Lip GYH
    J Am Coll Cardiol; 2019 Mar; 73(8):919-931. PubMed ID: 30819360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation Across BMI Categories: A Systematic Review and Meta-Analysis.
    Zhou Y; Ma J; Zhu W
    Am J Cardiovasc Drugs; 2020 Feb; 20(1):51-60. PubMed ID: 31342343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study.
    Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Renoux C; Paterson JM; Quail J; Matteau A;
    CMAJ Open; 2020; 8(4):E877-E886. PubMed ID: 33355273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study.
    Rahme E; Godin R; Nedjar H; Dasgupta K; Tagalakis V
    Thromb Res; 2021 Jul; 203():121-130. PubMed ID: 34000493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation.
    Nielsen-Kudsk JE; Korsholm K; Damgaard D; Valentin JB; Diener HC; Camm AJ; Johnsen SP
    JACC Cardiovasc Interv; 2021 Jan; 14(1):69-78. PubMed ID: 33413867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
    Alamneh EA; Chalmers L; Bereznicki LR
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation.
    Lutsey PL; Norby FL; Ensrud KE; MacLehose RF; Diem SJ; Chen LY; Alonso A
    JAMA Intern Med; 2020 Feb; 180(2):245-253. PubMed ID: 31764956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Oral Anticoagulants vs. Warfarin in Latin American Patients With Atrial Fibrillation: Evidence From Four
    Liu F; Wang Y; Luo J; Huang L; Zhu W; Yin K; Xue Z
    Front Cardiovasc Med; 2022; 9():841341. PubMed ID: 35310968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct oral anticoagulants versus warfarin for secondary prevention of cerebral infarction and bleeding in older adults with atrial fibrillation.
    Kumazawa R; Jo T; Matsui H; Fushimi K; Yasunaga H
    J Am Geriatr Soc; 2022 Jul; 70(7):2029-2039. PubMed ID: 35397114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Obese Patients with Atrial Fibrillation.
    Briasoulis A; Mentias A; Mazur A; Alvarez P; Leira EC; Vaughan Sarrazin MS
    Cardiovasc Drugs Ther; 2021 Apr; 35(2):261-272. PubMed ID: 33404923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct oral anticoagulants in atrial fibrillation following cardiac surgery: a systematic review and meta-analysis with trial sequential analysis.
    Koh KK; Ling RR; Tan SYS; Chen Y; Fan BE; Shekar K; Sule JA; Subbian SK; Ramanathan K
    Br J Anaesth; 2022 Aug; 129(2):154-162. PubMed ID: 35729010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation.
    Jackevicius CA; Lu L; Ghaznavi Z; Warner AL
    Circ Cardiovasc Qual Outcomes; 2021 Feb; 14(2):e007230. PubMed ID: 33541109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single center retrospective cohort study evaluating use of direct oral anticoagulants (DOACs) in morbidly obese veteran population.
    Patil T; Lebrecht M
    Thromb Res; 2020 Aug; 192():124-130. PubMed ID: 32473496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.